Get the Stockscreener App
77.17
0.01%
0.03
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $77.17, with a volume of 387.69K.
It is up +0.01% in the last 24 hours and down -12.39% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$77.20
Open:
$77.53
24h Volume:
387.69K
Relative Volume:
0.21
Market Cap:
$38.17B
Revenue:
$10.03B
Net Income/Loss:
$1.07B
P/E Ratio:
35.56
EPS:
2.17
Net Cash Flow:
$1.39B
1W Performance:
-3.10%
1M Performance:
-12.39%
6M Performance:
-15.07%
1Y Performance:
-20.11%
1-Day Range:
$77.00
$77.56
1-Week Range:
$77.00
$79.04
52-Week Range:
$77.00
$100.71
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
77.19 | 38.17B | 10.03B | 1.07B | 1.39B | 2.17 |
|
ISRG
Intuitive Surgical Inc
|
432.10 | 155.46B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
187.95 | 53.76B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
271.72 | 39.78B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
254.08 | 18.45B | 2.96B | 487.70M | 344.00M | 6.68 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Portfolio Shifts: Will Alcon Inc benefit from rate cutsTrade Entry Summary & Smart Swing Trading Techniques - خودرو بانک
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
Alcon AG stock hits 52-week low at $77.34 amid challenging year By Investing.com - Investing.com South Africa
Alcon AG stock hits 52-week low at $77.34 amid challenging year - Investing.com Australia
Growth Value: What is Alcon Inc.’s book value per share2025 Year in Review & High Accuracy Investment Signals - خودرو بانک
Gains Report: What is Bakkt Holdings Inc Equity Warrants 5 year growth outlook2025 Top Gainers & Free High Accuracy Swing Entry Alerts - خودرو بانک
Staar Surgical issues letter to stockholders regarding Alcon merger - Yahoo Finance
Trading Action: Is Alcon Inc forming a breakout patternJuly 2025 Volume & Fast Moving Stock Watchlists - خودرو بانک
Alcon upgraded to neutral by Redburn, operational execution cited - MSN
RBC Capital Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $100.73 - 富途牛牛
STAAR Surgical Announces Merger with Alcon - TipRanks
Fuchs Endothelial Corneal Dystrophy Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | ProQR Therapeutics, Kowa Pharmaceuticals, Trefoil Therapeutics, Alcon Inc., Emmecell - Barchart.com
51% Premium: Medical Device Leader Alcon to Acquire STAAR Surgical in Premium Cash Deal Worth $28 Per Share - Stock Titan
Alcon (ALC) Boosts Surgical Efficiency with Unity Vitreoretinal Cataract System - GuruFocus
Alcon Announces New Time and Motion Study Results Supporting Superior Efficiency - Business Wire
Risk Check: Whats the MACD signal for Alcon IncShare Buyback & Consistent Income Trade Ideas - خودرو بانک
Alcon (ALC) Receives a Buy from RBC Capital - The Globe and Mail
Swiss eye-care giant acquires Poulsbo medical device firm - The Business Journals
Aug Breakouts: How is Alcon Inc managing supply chain issuesWeekly Trend Report & Growth Focused Stock Reports - خودرو بانک
Alcon Sues Tesla, Musk Over AI-Generated Blade Runner 2049 Imagery - WebProNews
Aug Opening: Whats the beta of Alcon Inc stockJuly 2025 Update & High Accuracy Investment Signals - خودرو بانک
Alcon Acquires LumiThera to Boost Dry AMD Treatment Options - WebProNews
Eye care giant Alcon acquires LumiThera, a Seattle-area startup behind device that treats vision loss - GeekWire
STAAR Surgical's largest holder to vote against Alcon bid - MSN
Alcon up 4% as FDA approves Tryptyr drops for dry eye - MSN
The past year for Alcon (VTX:ALC) investors has not been profitable - Yahoo Finance
North America Vision Care Market Report 2025-2033 | EssilorLuxottica, Johnson & Johnson Vision, CooperVision, Bausch + Lomb, and Alcon Lead the 37.7 Bn Competitive Landscape - Yahoo Finance
Exclusive: Shareholder revolt threatens Alcon’s takeover of STAAR Surgical - Investing.com
New company OpZira formed following Alcon’s acquisition of LumiThera - Ophthalmology Times
Alcon AG stock hits 52-week low at 77.71 USD By Investing.com - Investing.com Nigeria
Alcon announces launch of wavelight plus, fully personalized LASIK treatment, in US and Canada - Ophthalmology Times
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders - GlobeNewswire Inc.
Hyperopia Market Overview: Epidemiology, Emerging Therapies, and Key Players | Featuring Nevakar, Zeimer Ophthalmic Systems AG, Carl Zeiss Meditec AG, AbbVie, Sydnexis, ALCON Inc., Bausch Health Compa - Barchart.com
Alcon AG stock hits 52-week low at 77.71 USD - Investing.com
Alcon launches first fully personalized LASIK treatment - Eyes On Eyecare
Alcon completes acquisition of LumiThera - Modern Retina
Swing Trade: Will Alcon Inc. benefit from rate cutsWeekly Gains Report & Real-Time Stock Price Movement Reports - Lancaster City Council
Does Alcon Inc. offer margin of safetyCPI Data & Technical Entry and Exit Alerts - Lancaster City Council
Alcon announces first fully personalized LASIK treatment with wavelight plus in the US and Canada - Eyes On Eyecare
North America Intraocular Lens Market Forecast and Company - GlobeNewswire
North America Intraocular Lens Market Forecast and Company Analysis Report 2025-2033 Featuring Alcon, Bausch, Hoya, Johnson & Johnson, STAAR Surgical, Carl Zeiss, Meditec, Novartis, and USIOL - uk.finance.yahoo.com
Eye Care’s Digital Revolution: Alcon’s ESCRS 2025 Launches Signal the Future of a $90B Market - MarketsandMarkets
Dana Lynn Alcon Obituary (2025)Price, UTMitchell Funeral Home, Inc.Price - Legacy.com
OpZira launches with LumiThera diagnostic product line - Eyes On Eyecare
Short Term Trend Reversal in Alcon Inc. PossibleJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
Candlestick Reversal Detected on Alcon Inc.’s ChartTrade Signal Summary & High Conviction Buy Zone Picks - beatles.ru
Alcon Inc. Volume Confirms Breakout — Analysts Bullish2025 Bull vs Bear & Smart Swing Trading Alerts - beatles.ru
Alcon Inc. Moves Into Bullish Territory Based on MACDJuly 2025 PreEarnings & Verified Momentum Watchlists - beatles.ru
Is Alcon Inc. Forming a Bottom PatternJuly 2025 Technicals & Free Accurate Trade Setup Notifications - beatles.ru
Alcon Launches Innovations and Highlights New Study Findings At ESCRS 2025 - MarketScreener
Alcon Inc. Recovery Potential Based on Technical ToolsAnalyst Downgrade & Real-Time Chart Pattern Alerts - beatles.ru
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):